Qiang Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qiang Chang has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Feng Lu
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
7 shared publications Feng Lu
Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou 510515, Guangdong, China
4 shared publicationsTing Su
Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510515, China
4 shared publicationsXingtang Niu
Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510515, China
4 shared publicationsXinhui Wang
Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510515, China
4 shared publications- Jianhua Gao
From the Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 11 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 103015
Sustained-release CGRP microspheres accelerate diabetic wound healing by synergistically promoting neurovascular regeneration through modulation of macrophage and endothelial cell functions
- 11 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 103015
Top Cited PapersOpen AccessSustained-release CGRP microspheres accelerate diabetic wound healing by synergistically promoting neurovascular regeneration through modulation of macrophage and endothelial cell functions
- 17 February 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (6) , 2287-2299
Removing Lipid Droplets Improves Fat Transplantation Outcomes in a Mouse Model through Suppressing Pro-fibrotic Macrophage Responses
Background The clinical efficacy and predictability of autologous fat grafting are frequently undermined by uncontrolled fibrosis and oil cyst formation. While lipid droplets (LDs) metabolic imbalance is recognized as a critical factor influencing graft outcomes, the underlying mechanisms linking LDs to adverse tissue remodeling remain poorly understood. Objectives This study aimed to elucidate the mechanistic impact of extracellular LDs on fat graft outcomes in a murine model, with a specific focus on their role in modulating macrophage-mediated inflammation and fibrosis. Method Fat grafts were transplanted into C57BL/6J mice and divided into two groups: an oil-retained group (control) and an oil-removed group (intervention). Grafts were harvested at serial timepoints (2–12 weeks) for comprehensive analysis, including histopathology (H&E, Masson's trichrome), quantitative PCR for inflammatory and fibrotic markers (TNF-α, IL-1β, IL-6, TGF-β), and immunofluorescence staining to assess macrophage polarization (CD86 for M1, CD206 for M2). Result The presence of excess extracellular LDs acted as a potent inflammatory trigger, driving a significant upregulation of pro-inflammatory cytokines, including TNF-α (2.4-fold), IL-6 (1.9-fold), and IL-1β (2.8-fold). This pro-inflammatory microenvironment was associated with a dominant M1 macrophage phenotype. Conversely, the preoperative removal of LDs fundamentally altered this response. The oil-removed group exhibited markedly superior outcomes, including a 1.25-fold greater volume retention (p < 0.01) and a 60% reduction in oil cyst area (p < 0.01) at 12 weeks. Mechanistically, these improvements were linked to a decisive shift in macrophage polarization toward a pro-regenerative M2 phenotype, as evidenced by a significantly higher CD206+/CD86+ cell ratio (1.76 vs. 0.86 in controls). Conclusion LDs overload exacerbated graft failure through M1 macrophage-mediated chronic inflammation and pathological fibrosis. Preoperative removal of these lipid droplets mitigates this detrimental inflammatory cascade, improves graft retention, and represents a critical and actionable strategy for enhancing the outcomes of clinical fat transplantation. Level of Evidence I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 17 February 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (6) , 2287-2299
Removing Lipid Droplets Improves Fat Transplantation Outcomes in a Mouse Model through Suppressing Pro-fibrotic Macrophage Responses
Background The clinical efficacy and predictability of autologous fat grafting are frequently undermined by uncontrolled fibrosis and oil cyst formation. While lipid droplets (LDs) metabolic imbalance is recognized as a critical factor influencing graft outcomes, the underlying mechanisms linking LDs to adverse tissue remodeling remain poorly understood. Objectives This study aimed to elucidate the mechanistic impact of extracellular LDs on fat graft outcomes in a murine model, with a specific focus on their role in modulating macrophage-mediated inflammation and fibrosis. Method Fat grafts were transplanted into C57BL/6J mice and divided into two groups: an oil-retained group (control) and an oil-removed group (intervention). Grafts were harvested at serial timepoints (2–12 weeks) for comprehensive analysis, including histopathology (H&E, Masson's trichrome), quantitative PCR for inflammatory and fibrotic markers (TNF-α, IL-1β, IL-6, TGF-β), and immunofluorescence staining to assess macrophage polarization (CD86 for M1, CD206 for M2). Result The presence of excess extracellular LDs acted as a potent inflammatory trigger, driving a significant upregulation of pro-inflammatory cytokines, including TNF-α (2.4-fold), IL-6 (1.9-fold), and IL-1β (2.8-fold). This pro-inflammatory microenvironment was associated with a dominant M1 macrophage phenotype. Conversely, the preoperative removal of LDs fundamentally altered this response. The oil-removed group exhibited markedly superior outcomes, including a 1.25-fold greater volume retention (p < 0.01) and a 60% reduction in oil cyst area (p < 0.01) at 12 weeks. Mechanistically, these improvements were linked to a decisive shift in macrophage polarization toward a pro-regenerative M2 phenotype, as evidenced by a significantly higher CD206+/CD86+ cell ratio (1.76 vs. 0.86 in controls). Conclusion LDs overload exacerbated graft failure through M1 macrophage-mediated chronic inflammation and pathological fibrosis. Preoperative removal of these lipid droplets mitigates this detrimental inflammatory cascade, improves graft retention, and represents a critical and actionable strategy for enhancing the outcomes of clinical fat transplantation. Level of Evidence I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 5 June 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (28) , 8470-8482
Synergistic integration of ADSCs and egg white hydrogel microspheres for accelerated wound regeneration
Accelerating wound healing poses a significant challenge in clinical practice, necessitating the exploration of innovative strategies. The development of biomaterials with tissue repair and regenerative properties represents a forefront approach to addressing this challenge; however, the functional characteristics and application methods of these materials remain limited. In this context, a novel bioactive micro carrier (Bio-MC) was developed from egg white hydrogel microspheres (EWMs) which served as a bio-niche incorporating adipose-derived stem cells (ADSCs). This formulation capitalizes on the intrinsic tissue reparative capabilities of stem cells, allowing for the sustained release of multiple growth factors. These factors, via paracrine signaling, promote the proliferation and migration of neighboring cells, thereby creating an environment that supports wound healing. Upon application to wound sites, Bio-MCs exhibited significant effectiveness in enhancing the healing process by promoting tissue regeneration, increasing collagen deposition, and facilitating vascularization. The paracrine signaling mediated by Bio-MCs has the potential to exert lasting beneficial effects on cells in a comprehensive and physiologically relevant manner. In comparison to conventional growth factor treatments, the Bio-MC offers enhanced application versatility and functional attributes, indicating substantial promise in the field of tissue repair and regeneration and representing a noteworthy advancement in the clinical management of wounds.
- 5 June 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (28) , 8470-8482
Synergistic integration of ADSCs and egg white hydrogel microspheres for accelerated wound regeneration
Accelerating wound healing poses a significant challenge in clinical practice, necessitating the exploration of innovative strategies. The development of biomaterials with tissue repair and regenerative properties represents a forefront approach to addressing this challenge; however, the functional characteristics and application methods of these materials remain limited. In this context, a novel bioactive micro carrier (Bio-MC) was developed from egg white hydrogel microspheres (EWMs) which served as a bio-niche incorporating adipose-derived stem cells (ADSCs). This formulation capitalizes on the intrinsic tissue reparative capabilities of stem cells, allowing for the sustained release of multiple growth factors. These factors, via paracrine signaling, promote the proliferation and migration of neighboring cells, thereby creating an environment that supports wound healing. Upon application to wound sites, Bio-MCs exhibited significant effectiveness in enhancing the healing process by promoting tissue regeneration, increasing collagen deposition, and facilitating vascularization. The paracrine signaling mediated by Bio-MCs has the potential to exert lasting beneficial effects on cells in a comprehensive and physiologically relevant manner. In comparison to conventional growth factor treatments, the Bio-MC offers enhanced application versatility and functional attributes, indicating substantial promise in the field of tissue repair and regeneration and representing a noteworthy advancement in the clinical management of wounds.
- 2 March 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (5) , e23520
Lipolysis inhibition improves the survival of fat grafts through ameliorating lipotoxicity and inflammation
Fat grafting is a promising technique for correcting soft tissue abnormalities, but oil cyst formation and graft fibrosis frequently impede the therapeutic benefit of fat grafting. The lipolysis of released oil droplets after grafting may make the inflammation and fibrosis in the grafts worse; therefore, by regulating adipose triglyceride lipase (ATGL) via Atglistatin (ATG) and Forskolin (FSK), we investigated the impact of lipolysis on fat grafts in this study. After being removed from the mice and chopped into small pieces, the subcutaneous fat from wild‐type C57BL/6J mice was placed in three different solutions for two hours: serum‐free cell culture medium, culture medium+FSK (50 μM), and culture medium+ATG (100 μM). Following centrifugation to remove water and free oil droplets, 0.3 mL of the fat particles per mouse was subcutaneously injected into the back of mice. Additionally, the subcutaneous fat grafting area was immediately injected with PBS (control group), ATG (30 mg/kg), and FSK (15 mg/kg) following fat transplantation. Detailed cellular events after grafting were investigated by histological staining, real‐time polymerase chain reaction, immunohistochemistry/immunofluorescent staining, and quantification. Two weeks after grafting, grafts treated with ATG showed lower expression of ATGL and decreased mRNA levels of TNFα and IL‐6. In contrast, grafts treated with ATG showed elevated expression levels of IL‐4 and IL‐13 compared to the control grafts. In addition, fewer apoptotic cells and oil cysts were observed in ATG grafts. Meanwhile, a higher CD206+/CD68+ ratio of macrophages and more CD31+ vascular endothelial cells existed in the 2‐month ATG grafts. In comparison to the control, ATG treatment improved the volume retention of grafts, and decreased graft fibrosis and oil cyst formation. By preventing oil droplet lipolysis, pharmacological suppression of ATGL shielded adipocytes from lipotoxicity following grafting. Additionally, ATG ameliorated the apoptosis and inflammation brought on by adipocyte death and oil droplet lipolysis in grafted fat. These all indicate that lipolysis inhibition improved transplanted fat survival and decreased the development of oil cysts and graft fibrosis, offering a potential postoperative pharmacological intervention for bettering fat grafting.
- 2 March 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (5) , e23520
Lipolysis inhibition improves the survival of fat grafts through ameliorating lipotoxicity and inflammation
Fat grafting is a promising technique for correcting soft tissue abnormalities, but oil cyst formation and graft fibrosis frequently impede the therapeutic benefit of fat grafting. The lipolysis of released oil droplets after grafting may make the inflammation and fibrosis in the grafts worse; therefore, by regulating adipose triglyceride lipase (ATGL) via Atglistatin (ATG) and Forskolin (FSK), we investigated the impact of lipolysis on fat grafts in this study. After being removed from the mice and chopped into small pieces, the subcutaneous fat from wild‐type C57BL/6J mice was placed in three different solutions for two hours: serum‐free cell culture medium, culture medium+FSK (50 μM), and culture medium+ATG (100 μM). Following centrifugation to remove water and free oil droplets, 0.3 mL of the fat particles per mouse was subcutaneously injected into the back of mice. Additionally, the subcutaneous fat grafting area was immediately injected with PBS (control group), ATG (30 mg/kg), and FSK (15 mg/kg) following fat transplantation. Detailed cellular events after grafting were investigated by histological staining, real‐time polymerase chain reaction, immunohistochemistry/immunofluorescent staining, and quantification. Two weeks after grafting, grafts treated with ATG showed lower expression of ATGL and decreased mRNA levels of TNFα and IL‐6. In contrast, grafts treated with ATG showed elevated expression levels of IL‐4 and IL‐13 compared to the control grafts. In addition, fewer apoptotic cells and oil cysts were observed in ATG grafts. Meanwhile, a higher CD206+/CD68+ ratio of macrophages and more CD31+ vascular endothelial cells existed in the 2‐month ATG grafts. In comparison to the control, ATG treatment improved the volume retention of grafts, and decreased graft fibrosis and oil cyst formation. By preventing oil droplet lipolysis, pharmacological suppression of ATGL shielded adipocytes from lipotoxicity following grafting. Additionally, ATG ameliorated the apoptosis and inflammation brought on by adipocyte death and oil droplet lipolysis in grafted fat. These all indicate that lipolysis inhibition improved transplanted fat survival and decreased the development of oil cysts and graft fibrosis, offering a potential postoperative pharmacological intervention for bettering fat grafting.
- Open Access
- 11 January 2024
- Published by Elsevier in Journal of Advanced Research
- Vol. 66, 237-249
Hierarchical double-layer microneedles accomplish multicenter skin regeneration in diabetic full-thickness wounds
- 11 January 2024
- Published by Elsevier in Journal of Advanced Research
- Vol. 66, 237-249
Open AccessHierarchical double-layer microneedles accomplish multicenter skin regeneration in diabetic full-thickness wounds
- Open Access
- 1 January 2024
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 15
Immunomodulation in diabetic wounds healing: The intersection of macrophage reprogramming and immunotherapeutic hydrogels
Diabetic wound healing presents a significant clinical challenge due to the interplay of systemic metabolic disturbances and local inflammation, which hinder the healing process. Macrophages undergo a phenotypic shift from M1 to M2 during wound healing, a transition pivotal for effective tissue repair. However, in diabetic wounds, the microenvironment disrupts this phenotypic polarization, perpetuating inflammation, and impeding healing. Reprograming macrophages to restore their M2 phenotype offers a potential avenue for modulating the wound immune microenvironment and promoting healing. This review elucidates the mechanisms underlying impaired macrophage polarization toward the M2 phenotype in diabetic wounds and discusses novel strategies, including epigenetic and metabolic interventions, to promote macrophage conversion to M2. Hydrogels, with their hydrated 3D cross-linked structure, closely resemble the physiological extracellular matrix and offer advantageous properties such as biocompatibility, tunability, and versatility. These characteristics make hydrogels promising candidates for developing immunomodulatory materials aimed at addressing diabetic wounds. Understanding the role of hydrogels in immunotherapy, particularly in the context of macrophage reprograming, is essential for the development of advanced wound care solutions. This review also highlights recent advancements in immunotherapeutic hydrogels as a step toward precise and effective treatments for diabetic wounds.
- 1 January 2024
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 15
Open AccessImmunomodulation in diabetic wounds healing: The intersection of macrophage reprogramming and immunotherapeutic hydrogels
Diabetic wound healing presents a significant clinical challenge due to the interplay of systemic metabolic disturbances and local inflammation, which hinder the healing process. Macrophages undergo a phenotypic shift from M1 to M2 during wound healing, a transition pivotal for effective tissue repair. However, in diabetic wounds, the microenvironment disrupts this phenotypic polarization, perpetuating inflammation, and impeding healing. Reprograming macrophages to restore their M2 phenotype offers a potential avenue for modulating the wound immune microenvironment and promoting healing. This review elucidates the mechanisms underlying impaired macrophage polarization toward the M2 phenotype in diabetic wounds and discusses novel strategies, including epigenetic and metabolic interventions, to promote macrophage conversion to M2. Hydrogels, with their hydrated 3D cross-linked structure, closely resemble the physiological extracellular matrix and offer advantageous properties such as biocompatibility, tunability, and versatility. These characteristics make hydrogels promising candidates for developing immunomodulatory materials aimed at addressing diabetic wounds. Understanding the role of hydrogels in immunotherapy, particularly in the context of macrophage reprograming, is essential for the development of advanced wound care solutions. This review also highlights recent advancements in immunotherapeutic hydrogels as a step toward precise and effective treatments for diabetic wounds.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 15
Microenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics
The rising prevalence of diabetes has underscored concerns surrounding diabetic wounds and their potential to induce disability. The intricate healing mechanisms of diabetic wounds are multifaceted, influenced by ambient microenvironment, including prolonged hyperglycemia, severe infection, inflammation, elevated levels of reactive oxygen species (ROS), ischemia, impaired vascularization, and altered wound physicochemical properties. In recent years, hydrogels have emerged as promising candidates for diabetic wound treatment owing to their exceptional biocompatibility and resemblance to the extracellular matrix (ECM) through a three-dimensional (3D) porous network. This review will first summarize the microenvironment alterations occurring in the diabetic wounds, aiming to provide a comprehensive understanding of its pathogenesis, then a comprehensive classification of recently developed hydrogels will be presented, encompassing properties such as hypoglycemic effects, anti-inflammatory capabilities, antibacterial attributes, ROS scavenging abilities, promotion of angiogenesis, pH responsiveness, and more. The primary objective is to offer a valuable reference for repairing diabetic wounds based on their unique microenvironment. Moreover, this paper outlines potential avenues for future advancements in hydrogel dressings to facilitate and expedite the healing process of diabetic wounds.
- 1 January 2024
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 15
Top Cited PapersOpen AccessMicroenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics
The rising prevalence of diabetes has underscored concerns surrounding diabetic wounds and their potential to induce disability. The intricate healing mechanisms of diabetic wounds are multifaceted, influenced by ambient microenvironment, including prolonged hyperglycemia, severe infection, inflammation, elevated levels of reactive oxygen species (ROS), ischemia, impaired vascularization, and altered wound physicochemical properties. In recent years, hydrogels have emerged as promising candidates for diabetic wound treatment owing to their exceptional biocompatibility and resemblance to the extracellular matrix (ECM) through a three-dimensional (3D) porous network. This review will first summarize the microenvironment alterations occurring in the diabetic wounds, aiming to provide a comprehensive understanding of its pathogenesis, then a comprehensive classification of recently developed hydrogels will be presented, encompassing properties such as hypoglycemic effects, anti-inflammatory capabilities, antibacterial attributes, ROS scavenging abilities, promotion of angiogenesis, pH responsiveness, and more. The primary objective is to offer a valuable reference for repairing diabetic wounds based on their unique microenvironment. Moreover, this paper outlines potential avenues for future advancements in hydrogel dressings to facilitate and expedite the healing process of diabetic wounds.
- Open Access
- 2 June 2023
- Published by Elsevier in Materials Today Bio
- Vol. 20, 100687
Oxygen-releasing biomaterials for chronic wounds breathing: From theoretical mechanism to application prospect
- 2 June 2023
- Published by Elsevier in Materials Today Bio
- Vol. 20, 100687
Open AccessOxygen-releasing biomaterials for chronic wounds breathing: From theoretical mechanism to application prospect
- 25 April 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (19) , 4330-4345
Facile synthesis of hydroxypropyl chitosan-egg white hydrogel dressing with antibacterial and antioxidative activities for accelerating the healing of burn wounds
Burn injury is the fourth most common injury worldwide. Deep partial-thickness burns are susceptible to bacterial infections due to the absence of a skin shield, which can lead to severe pain, scarring, and even death. Therefore, developing a wound dressing that can promote wound repair accompanied by excellent antibacterial effects is crucial for clinical application. Herein, a facile self-healing hydroxypropyl chitosan–egg white hydrogel (HPCS–EWH) with excellent biocompatibility, antioxidant activity, anti-inflammation and antibacterial properties was prepared. This physical crosslinking hydrogel was endowed with the intrinsic merits of its parental components, such as reactive oxygen species (ROS) scavenging, antibiosis, and thriving cell growth in vitro. In an in vivo model of Staphylococcus aureus-infected burn wounds, HPCS–EWH could accelerate wound healing due to its anti-inflammatory and antibacterial activities, and promote cell proliferation and angiogenesis. Therefore, HPCS–EWH could be used to heal deep partial-thickness skin burn wounds.
- 25 April 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (19) , 4330-4345
Facile synthesis of hydroxypropyl chitosan-egg white hydrogel dressing with antibacterial and antioxidative activities for accelerating the healing of burn wounds
Burn injury is the fourth most common injury worldwide. Deep partial-thickness burns are susceptible to bacterial infections due to the absence of a skin shield, which can lead to severe pain, scarring, and even death. Therefore, developing a wound dressing that can promote wound repair accompanied by excellent antibacterial effects is crucial for clinical application. Herein, a facile self-healing hydroxypropyl chitosan–egg white hydrogel (HPCS–EWH) with excellent biocompatibility, antioxidant activity, anti-inflammation and antibacterial properties was prepared. This physical crosslinking hydrogel was endowed with the intrinsic merits of its parental components, such as reactive oxygen species (ROS) scavenging, antibiosis, and thriving cell growth in vitro. In an in vivo model of Staphylococcus aureus-infected burn wounds, HPCS–EWH could accelerate wound healing due to its anti-inflammatory and antibacterial activities, and promote cell proliferation and angiogenesis. Therefore, HPCS–EWH could be used to heal deep partial-thickness skin burn wounds.